Renal Cancer - Results from #4120

Identification of eight key miRNAs associated with renal cell carcinoma: A meta-analysis October 25, 2018

The contemporary role of lymph node dissection in the management of renal cell carcinoma October 25, 2018

2017 AUA Renal Mass and Localized Renal Cancer Guidelines: Imaging Implications October 24, 2018

Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples October 24, 2018

MiR-425 involves in the development and progression of renal cell carcinoma by inhibiting E2F6 October 24, 2018

New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma October 24, 2018

[Chloroquine inhibits viability of renal carcinoma cells and enhances sunitinib-induced caspase-dependent apoptosis] October 24, 2018

Novel splicing in IGFN1 intron 15 and role of stable G-quadruplex in the regulation of splicing in renal cell carcinoma October 24, 2018

Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies October 23, 2018

Impact of Perioperative Blood Transfusions on the Outcomes of Patients Undergoing Kidney Cancer Surgery: A Systematic Review and Pooled Analysis October 23, 2018

Boiling Histotripsy Ablation of Renal Cell Carcinoma in the Eker Rat Promotes a Systemic Inflammatory Response October 23, 2018

Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls October 23, 2018

Frontline immunotherapy treatment with nivolumab and ipilimumab in metastatic renal cell cancer: a new standard of care October 22, 2018

Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma October 22, 2018

Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma October 22, 2018

PTEN Expression, Not Mutation Status for TSC1, TSC2 or mTOR, Correlates With Outcome on Everolimus in Patients With Renal Cell Carcinoma Treated on RECORD-3 October 22, 2018

Axitinib Versus Placebo as an Adjuvant Treatment for Renal Cell Carcinoma: Results From the ATLAS Trial October 20, 2018

[Place of partial nephrectomy assisted by robot: Review of the literature at the time of a request for a specific nomenclature] October 19, 2018

Tumor infiltrating CD19+ B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors October 19, 2018

The Role of YB1 in Renal Cell Carcinoma Cell Adhesion October 19, 2018

Page 207 of 456